Heart failure & cardiomyopathiesCohort study

Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction

JACC Heart FailPublished

  • Retrospective registry study
  • multicentre
  • GWTG-HF Registry 2017-2020

Authors' conclusion

Nearly 1 in 6 patients received all indicated HF-related medications on admission, increasing to 1 in 3 on discharge with an average of 1 new medication initiation.

Study context

Population
Hospitalised patients with heart failure with reduced ejection fraction (HFrEF) in the GWTG-HF Registry, 2017–2020
Participants
50,170 patients · 160 sites
Outcome
Opportunities for and achievement of HF medication initiation (7 evidence-based HF-related medications: eligible, used before admission, prescribed at discharge)
Follow-up
Hospitalisation (admission to discharge)

Main finding

As reported in the abstract

Evidence-based HF medications per patient
Eligible medications, mean
3.9 ± 1.1
Used before admission, mean
2.1 ± 1.3
Prescribed on discharge, mean
3.0 ± 1.0
Receiving all indicated medications at admission
14.9%
Receiving all indicated medications at discharge
32.8%
Mean net gain in medications
0.9 ± 1.3
Mean length of stay (days)
5.6 ± 5.3

Observational data: associations, not effects.

Further findings

Odds of medication initiation over time · 2017-2020

Comparisonadjusted OR (95% CI)
study period · increased during the study period1.08 (1.06–1.10)

Factors associated with heart failure (HF) medication initiation (multivariable analysis)

Lower odds of initiation with older age, female sex, pre-existing conditions (stroke, peripheral arterial disease, pulmonary disease, renal insufficiency) and rural location

Original publication

Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. Published 14 June 2023. doi:10.1016/j.jchf.2023.04.015

Summarised from the published abstract; every number is checked against it